Analysis of State-Level Drug Pricing Transparency Laws in the United States.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31553467.
- Also identified by DOI 10.1001/jamanetworkopen.2019.12104 and PMC identifier 6763978.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study examines state drug pricing transparency laws enacted to increase supply chain price transparency in the United States.
Medical subject headings
- Community-Institutional Relations
- Costs and Cost Analysis
- Information Dissemination
- Legislation, Drug
- Prescription Drugs